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The recent emergence of H1N1 (swine ﬂu) illustrates the
ability of the inﬂuenza virus to create antigens new to the
human immune system, even within a given hemaggluti-
nin and neuraminidase subtype. This new H1N1 strain is
sufﬁciently distinct, for example, from the A/Brisbane/59/
2007 (H1N1)-like virus strain of inﬂuenza in the 2008/09
Northern hemisphere vaccine that protection is not
expected to be substantial. The human immune system
responds primarily to the ﬁve epitope regions of the
hemagglutinin protein. By determining the fraction of
amino acids that differ between a vaccine strain and a
viral challenge strain in the dominant epitope regions, a
measure of antigenic distance that correlates with epide-
miological studies of H3 inﬂuenza A vaccine efﬁcacy in
humans with R
2 5 0.81 is derived. This measure of anti-
genic distance is called pepitope. The relation between
vaccine efﬁcacy and pepitope is given by E 5 0.47 – 2.47 3
pepitope. We here identify the epitope regions of H1
hemagglutinin, so that vaccine efﬁcacy may be reliably
estimated for H1N1 inﬂuenza A.
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Introduction
The recent outbreak of H1N1 (swine ﬂu) has caused immedi-
ate international concern. From its earliest case in
mid-March 2009 to mid-May 2009, 8000–9000 infections
and 70–80 deaths were recorded in 40–50 countries and
regions, and as of mid-May, over 90% of infections and
deaths were in Mexico and the USA (World Health
Organization, 2009). Historically, three subtypes of inﬂuenza
A virus have been able to circulate in the human population.
The Spanish ﬂu pandemic in 1918–20 was H1N1, which cir-
culated in the world until 1957. H1N1 reappeared in 1977
and persists today (Nakajima et al., 1978). The Asian ﬂu
pandemic in 1956–58 was H2N2, which spread widely in
the human population during the time interval 1957–68
(Palese et al., 2006). The Hong Kong ﬂu pandemic in 1968–
69 was H3N2, which has circulated in the human population
as the dominant subtype until recently (Palese et al., 2006).
Other subtypes rarely infected humans, although cases of
H5N1 and H9N2 have been reported.
The 2009 swine ﬂu virus possesses H1 hemagglutinin
(HA) and N1 neuraminidase on the surface of the virion, of
which the hemagglutinin is the main target of host anti-
bodies. The human immune system responds primarily to the
ﬁve epitope regions of the hemagglutinin protein (Bush
et al., 1999; Macken et al., 2001). Host antibodies bind to
ﬁve epitopes in hemagglutinin and lead to high escape evo-
lution rates of amino acids in the epitopes. An early identiﬁ-
cation of H1 epitopes was carried out by antibody mapping
of the A/PR/8/1934 (H1) hemagglutinin, with an additional
study of laboratory mutations (Caton et al., 1982). However,
these H1 epitopes contain far fewer amino acids than do the
epitopes in H3 determined by modern methods (Macken
et al., 2001) and are incomplete. Alignment of H1 strains in
1918–2009 indicates many mutation positions outside the
originally identiﬁed epitopes. We here use sequence align-
ment and information entropy to complete the deﬁnition of
H1 epitopes.
Vaccination is an effective way to reduce the inﬂuenza
morbidity and mortality. The efﬁcacies of inﬂuenza vaccines
vary from year to year, in part due to different antigenic dis-
tances between the circulating inﬂuenza strains and the
vaccine. Antigenic distance between a vaccine strain and a
viral strain can be estimated by the number of mutations in
the hemagglutinin sequence between the two strains (Smith
et al., 1999, 2004). Ferret animal model studies are used to
further reﬁne the notion of antigenic distance. These
methods correlate with epidemiological studies of vaccine
efﬁcacy in humans with R
2 ¼ 0.59 and 0.43–0.57, respect-
ively (Gupta et al., 2006; Zhou et al., 2009). By considering
only those mutations that occur in the dominant epitope, the
pepitope theory provides a prediction of vaccine efﬁcacy that
correlates with epidemiological studies of vaccine efﬁcacy in
humans with R
2 ¼ 0.81.
Vaccine efﬁcacy has a linear correlation with the antigenic
distance between the vaccine strain and the circulating virus
strain (Gupta et al., 2006; Zhou et al., 2009). Since pepitope
correlates well with inﬂuenza vaccine efﬁcacy in humans, it
can be used to estimate antigenic distance. For example,
when pepitope is larger than 0.19, the vaccine no longer offers
protection. This correlation can be used to ﬁnd optimal
strains for vaccine design with minimal antigenic distance
from expected circulating strains. Here we calculate the anti-
genic distance for H1 inﬂuenza A and apply the method to
evaluate efﬁcacy of a candidate swine ﬂu vaccine.
Methods
Mapping the epitope from H3 hemagglutinin to H1
hemagglutinin
In this paper, the amino acid positions of H1 (A/PR/8/1934)
and H3 (A/Aichi/2/1968) hemagglutinin are denoted using
H1 and H3 numbering, respectively (Winter et al., 1981;
Nobusawa et al., 1991). Two hemagglutinin sequences of A/
PR/8/1934 (H1) and A/Aichi/2/1968 (H3) are aligned using
ClustalW. Amino acids in H1 sequence corresponding to
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Similarity between H3 epitopes and corresponding mapped H1
epitopes was veriﬁed by aligning their three-dimensional struc-
tures (PDB code: H3 ¼ 1HGF and H1 ¼ 1RU7). The RMSD
values of alpha carbons in ﬁve epitopes between H3 and H1
are 2.18, 0.63, 1.19, 2.43 and 1.90 A ˚,r e s p e c t i v e l y .
The HA alignment of A/California/04/2009 with A/PR/8/
1934 and of A/California/04/2009 with A/Aichi/2/1968
shows that neither A/PR/8/1934 nor A/Aichi/2/1968 has a
gap-free alignment with A/California/04/2009. Thus, a new
numbering scheme is required for the 2009 H1N1 (‘swine
ﬂu’) hemagglutinin. The new numbering starts at the same
amino acid position as the H1 numbering (Winter et al.,
1981; Nobusawa et al., 1991). Amino acid 130 in A/
California/04/2009 corresponds to a gap in A/PR/8/1934,
indicating that amino acid position .130 in A/California/04/
2009 has the number equal to 1 plus the corresponding
number of the amino acid in A/PR/8/1934. In Table I, we
use the A/California/04/2009 numbering scheme. HA align-
ment of swine ﬂu strains deposited in NCBI and GISAID up
until 18 May 2009 shows that no mutation occurred in amino
acid 130. By examining the three-dimensional structure of A/
PR/8/1934 (PDB code: 1RU7), we ﬁnd that amino acid 129
(A/PR/8/1934 numbering) is exposed and position 130 is
partially buried inside the molecule. Consequently, although
amino acid 130 (A/California/04/2009 numbering) in swine
ﬂu HA may or may not be signiﬁcant to antibody binding,
we have no evidence that it is in the epitope.
Extension of mapped epitope using entropy method
The deﬁnition of information entropy of site k is
SðkÞ¼ 
X 20
i¼1
ni
N
ln
ni
N
where ni is the number of times that amino acid i (i ¼ 1–20)
is found in site k of the aligned full-length strains. N is the
number of those full-length sequences, equal to 2294.
The threshold of the information entropy values to identify
epitopes is determined adaptively. Amino acids in epitopes
are under immune pressure selection and evolve to avoid rec-
ognition by antibodies, yielding large information entropy
values for amino acids in epitopes among all H1 strains.
Additionally, classical epitopes are deﬁned to be on the
surface of the three-dimensional structure of the hemaggluti-
nin. We decreased the entropy threshold until amino acids
inside the structure constitute a signiﬁcant proportion of
those amino acids newly incorporated into the epitopes.
Here, we select 0.075 as the threshold.
Phylogenetic tree and its root
Three hundred and twenty H1N1 swine ﬂu protein sequences
as of 18 May 2009 were downloaded from the NCBI and
GISAID databases. ClustalW is applied to align these strains.
Two hundred and sixty-six sequences containing residues
27–324 (A/California/04/2009 numbering, modiﬁed from
Caton et al., 1982) were used to create the phylogenic tree
with PHYLIP (Felsenstein, 1989). Two hundred and sixty-six
subsequences that included residues 27–324 were extracted,
and duplicated subsequences were removed. The 23 unique
aligned subsequences were then used as the input of the
program PHYLIP. The distance matrix from protein
sequences (protdist) and the Fitch–Margoliash and least
squares methods with evolutionary clock (kitsch)
(Felsenstein, 1989) were sequentially applied to generate the
phylogenic tree in Fig. 1. The output of protdist is the input
of kitsch. In the phylogenetic tree, the strain A/California/07/
2009 (FJ966974) is one of the outgroups, which are closest
to the root.
Calculation of pepitope
The antigenic distance between two strains is calculated from
the amino acid sequence in ﬁve epitopes of hemagglutinin.
For each epitope, the P-value is deﬁned as the proportion of
different amino acids between these two strains. The largest
of the ﬁve P-values is deﬁned as pepitope, and the correspond-
ing epitope is deﬁned as the dominant epitope (Gupta et al.,
2006; Zhou et al., 2009).
Results
Antigenic distance
As of 18 May 2009, there are 320 H1N1 swine ﬂu strains
in the NCBI and GISAID databases, and we focus on the
interval covering residues 27–324 (A/California/04/2009
numbering, modiﬁed from Caton et al., 1982) in 266 of 320
sequences covering this interval. Among these 266
sequences, the closest strain to the root of a phylogenetic
reconstruction (Felsenstein, 1989) is A/California/07/2009
(FJ966974) (Fig. 1). There are 20 mutations in the population
of sequences, referenced to this strain, with a maximum
Hamming distance of 4. Using the pepitope method, we ﬁnd
the largest pepitope value is 0.059 (dominant epitope ¼ E).
A/California/04/2009 (FJ966082) is a candidate for vaccine
design. There are 20 mutations in the population of
sequences, referenced to A/California/04/2009, with a
maximum Hamming distance of 5. The largest pepitope value
between this candidate strain and all sequences deposited to
date is 0.059 (dominant epitope ¼ E), suggesting a worst-case
Table I. Amino acids in epitopes A, B, C, D and E of H1 (A/California/04/
2009 numbering, modiﬁed from Caton et al., 1982)
Epitope Amino acids
A 118 120 121 122 126 127 128 129 132 133 134
135 137 139 140 141 142 143 146 147 149 165
252 253
B 124 125 152 153 154 155 156 157 160 162 183
184 185 186 187 189 190 191 193 194 195 196
C 3 43 53 63 73 84 04 14 34 44 52 6 92 7 02 7 12 7 2
273 274 276 277 278 283 288 292 295 297 298
302 303 305 306 307 308 309 310
D 89 94 95 96 113 117 163 164 166 167 168 169
170 171 172 173 174 176 179 198 200 202 204
205 206 207 208 209 210 211 212 213 214 215
216 222 223 224 225 226 227 235 237 239 241
243 244 245
E 4 74 85 05 15 35 45 65 75 86 66 86 97 07 17 27 3
74 75 78 79 80 82 83 84 85 86 102 257 258 259
260 261 263 267
For A/PR/8/1934 numbering, amino acid numbers above 130 would have 1
subtracted from them.
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that of a perfect-match, pepitope ¼ 0, vaccine.
Epitope identiﬁcation
To construct pepitope for H1N1, the identities of the epitope
regions in H1 are needed. An early antibody mapping exper-
iment on the PR/8 strain of H1N1 identiﬁed 9, 6, 6, 5 and 6
amino acids belonging to the ﬁve epitopes Sa, Sb, Ca1,C a 2
and Cb, respectively (Caton et al., 1982). These H1 epitopes
map by sequence homology to the H3 epitopes BþD, B,
CþD, AþD and E, respectively. Interestingly, for those H1
epitopes that map to multiple H3 epitopes, individual anti-
bodies bound to all H1 epitopes mapping to the same set of
H3 epitopes, suggesting that the identiﬁcation of the H1 epi-
topes may be subject to reﬁnement. The number of amino
acids determined by antibody mapping to be in the ﬁve
epitope residues of H1 is about one-third of the number of
amino acids identiﬁed in the ﬁve epitopes of H3 inﬂuenza A
(Smith et al., 1999, 2004).
We determined the likely remaining members of the ﬁve
epitope regions in H1 by information entropy methods. On 5
May 2009, we downloaded all 2735 H1 human inﬂuenza A
strains from NCBI. We retained the 2294 full-length
sequences. We constructed a sequence entropy diagram
(Fig. 2) from these data. The reﬁned H1 epitopes were
constructed by (i) mapping the known H3 epitopes (Smith
et al., 1999, 2004) to the H1 sequence, in rough agreement
with the skeleton of sites identiﬁed by early antibody
mapping experiments (Caton et al., 1982) (sequence
Fig. 1. Phylogenetic tree of swine ﬂu hemagglutinins deposited in NCBI and GISAID until 18 May 2009. For each tip containing over two strains,
representative strains are marked.
Fig. 2. Sequence entropy for the human strains of H1 (A/PR/8/1934
numbering, as in Caton et al., 1982). Positions belonging to predicted
epitopes are color coded by the epitope identity.
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to A/Aichi/2/1968), and (ii) 31 additional sites identiﬁed as
being under selective immune pressure, on the surface of the
hemagglutinin protein, and with information entropy values
.0.075.
Interestingly, eight amino acids were identiﬁed with infor-
mation entropy .0.075 that were outside the conventional
deﬁnition of epitopes. Three of these were in the tail region
of the hemagglutinin (positions 3, 314 and 320, numbering
as in Caton et al., 1982). The other ﬁve were not surface resi-
dues (positions 61, 174, 233, 248 and 249) (Fig. 3).
Although these residues can affect the geometry at the
surface, and so can be under selective pressure, they are not
available for presentation to antibodies and so cannot be
within a classically deﬁned antibody epitope.
Discussion
With the epitopes in H1 identiﬁed, pepitope can be constructed
for H1 inﬂuenza A. The parameter pepitope provides a quanti-
tative deﬁnition of antigenic distance. With this measure of
antigenic distance, vaccine strains as ‘close’ as possible to
potential circulating strains can be identiﬁed. This capability
should be useful in the design of the H1N1 component of
the annual inﬂuenza vaccine. This capability should also be
useful for special situation H1N1 vaccines, such as a vaccine
for the recently emerged swine ﬂu.
The pepitope measure of antigenic distance can be used to
estimate vaccine efﬁcacy. Vaccine efﬁcacy is (u2v)/u, where
u is the probability (or rate) that unvaccinated people are
infected and v the probability (or rate) that vaccinated people
are infected. By analogy with the H3N2 study (Gupta et al.,
2006; Zhou et al., 2009), we expect vaccine efﬁcacy will be
well predicted by the equation E ¼ 0.47–2.47   pepitope.
This equation predicts, for example, that a single mutation in
dominant epitope B would lead to a vaccine efﬁcacy that is
76.1% of that of a perfect match between vaccine and virus.
This equation also predicts that vaccine efﬁcacy is no longer
positive for pepitope . 0.19.
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Fig. 3. Color-coded epitopes in the H1 structure (PDB code: 1RU7).
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